Human Immunodeficiency Virus Protease Inhibitor Ritonavir Inhibits Cholesterol Efflux from Human Macrophage-Derived Foam Cells
- 1 July 2007
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 171 (1) , 304-314
- https://doi.org/10.2353/ajpath.2007.060965
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Increased Collagen Deposition and Elevated Expression of Connective Tissue Growth Factor in Human Thoracic Aortic DissectionCirculation, 2006
- Reverse cholesterol transport and cholesterol efflux in atherosclerosisQJM: An International Journal of Medicine, 2005
- HIV protease inhibitor ritonavir increases endothelial monolayer permeabilityBiochemical and Biophysical Research Communications, 2005
- Ginsenosides block HIV protease inhibitor ritonavir-induced vascular dysfunction of porcine coronary arteriesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Endothelin‐1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin‐1British Journal of Pharmacology, 2005
- HIV protease inhibitor ritonavir decreases endothelium-dependent vasorelaxation and increases superoxide in porcine arteriesCardiovascular Research, 2004
- Tumor necrosis factor signalingCell Death & Differentiation, 2003
- Lipopolysaccharide Down Regulates Both Scavenger Receptor B1 and ATP Binding Cassette Transporter A1 in RAW CellsInfection and Immunity, 2002
- Apolipoprotein Specificity for Lipid Efflux by the Human ABCAI TransporterBiochemical and Biophysical Research Communications, 2001
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993